one8zero8 LLC Invests $533,000 in CME Group Inc. $CME

one8zero8 LLC bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,416 shares of the financial services provider’s stock, valued at approximately $533,000.

Several other hedge funds have also recently added to or reduced their stakes in CME. Whipplewood Advisors LLC increased its position in shares of CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership purchased a new stake in shares of CME Group during the 4th quarter worth $27,000. Hilton Head Capital Partners LLC purchased a new stake in shares of CME Group during the 4th quarter worth $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of CME Group during the second quarter worth $28,000. Finally, Legacy Wealth Managment LLC ID grew its stake in shares of CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent analyst reports. Piper Sandler dropped their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Raymond James Financial reaffirmed an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research report on Thursday, July 2nd. The Goldman Sachs Group dropped their price objective on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective on the stock in a report on Thursday, June 18th. Finally, Morgan Stanley raised their target price on CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus price target of $288.56.

CME Group Stock Down 1.7%

CME opened at $266.94 on Thursday. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $95.99 billion, a P/E ratio of 22.64, a price-to-earnings-growth ratio of 3.16 and a beta of 0.23. The business’s 50-day simple moving average is $250.89 and its 200-day simple moving average is $279.81.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business’s revenue was up .8% on a year-over-year basis. During the same period in the prior year, the firm earned $2.96 EPS. Analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a $1.30 dividend. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s payout ratio is currently 44.11%.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard bought 325 shares of the stock in a transaction dated Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.